Introduction Aggressive variants of papillary thyroid cancer (PTC) have been described with
increasing frequency. These variants include diffuse sclerosing variant, tall cell variant …

Thyroid cancer is one of the few malignancies that are increasing in incidence. Recent
advances have improved our understanding of its pathogenesis; these include the …

Context: Because very few studies have examined the correlation between BRAF mutations
and clinicopathological features of papillary thyroid carcinoma (PTC), we analyzed here a …

Background: It has been reported that KRAS mutations (and to a lesser extent KRAS
mutations with the BRAF V600E mutation) negatively affect response to anti-epidermal …

This article reviews the small percentage of thyroid tumours that are not classified as classic
papillary thyroid carcinoma, follicular thyroid carcinoma, and medullary thyroid carcinoma. It …

Context: Evaluation of the degree of neoplastic infiltration beyond the thyroid capsule
remains a unique parameter that can be evaluated by histopathological examination to label …

The V600E mutation of the B-type Raf kinase (BRAF) gene is a common event in papillary
thyroid carcinoma (PTC) and seems to play a key role in the development and progression …

Purpose The incidence of thyroid carcinoma has increased globally in the past years.
Papillary thyroid carcinoma (PTC) is the most frequent neoplasm of the thyroid gland …

Background Among gynecologic cancers, ovarian cancer is the second most common and
has the highest death rate. Cancer is a genetic disorder and arises due to the accumulation …

This review addresses the impact of molecular alterations on the diagnosis and prognosis of
differentiated thyroid carcinoma (DTC), including papillary, follicular, and well-differentiated …